Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Baxter International Community
NYSE:BAX Community
3
Narratives
written by author
0
Comments
on narratives written by author
26
Fair Values set
on narratives written by author
Create a narrative
Baxter International
Popular
Undervalued
Overvalued
Community Investing Ideas
Baxter International
AN
AnalystHighTarget
Consensus Narrative from 16 Analysts
Global Aging And Digital Health Will Expand Advanced Hospital Care
Key Takeaways Targeted portfolio optimization and operational efficiency initiatives are driving higher margins, profitability, and sustained growth in core business areas. Strong innovation in digital health and competitive new product launches position Baxter to benefit from global demand for advanced, outcome-based healthcare solutions.
View narrative
US$51.86
FV
44.5% undervalued
intrinsic discount
6.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Baxter International
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Novum IQ Pump Expansion And Upgrades Will Create Market Opportunities
Key Takeaways Focus on verticalized operating model and digital enhancements aims to drive innovation, execution, and profitable growth, boosting future revenue and net margins. Investments in Novum IQ pump and supply chain optimization target market share capture and margin expansion amidst tariff challenges.
View narrative
US$38.03
FV
24.3% undervalued
intrinsic discount
5.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
1 day ago
author updated this narrative
Baxter International
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Global Pricing Pressures And Tariffs Will Erode Margins
Key Takeaways Persistent pricing and supply chain pressures, combined with integration challenges, threaten Baxter’s profitability and undermine expected efficiency gains from portfolio changes. Heavy reliance on mature inpatient-focused products exposes Baxter to competitive, structural, and demand risks as healthcare shifts to outpatient and home-based care models.
View narrative
US$28.00
FV
2.8% overvalued
intrinsic discount
3.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
22 days ago
author updated this narrative
Your Valuation for
BAX
BAX
Baxter International
Your Fair Value
US$
Current Price
US$28.77
59.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-3b
14b
2015
2018
2021
2024
2025
2027
2030
Revenue US$13.6b
Earnings US$1.9b
Advanced
Set Fair Value